Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...
SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced today an update to the ArteraAI Prostate Test ...
THIS YEAR, IT’S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there’s no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...
Anglia Ruskin University (ARU) provides funding as a member of The Conversation UK. The finger-up-the-bottom examination for prostate cancer has been drawn into question. An international panel of ...
A prostate screening test can help to detect early signs of prostate cancer.
Artera, the Los Altos, California-based developer of tools to diagnose cancer, has launched the first artificial intelligence (AI) test to guide patients in making informed decisions between active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results